Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer

Published:2024-08-12 Issue:12 Volume:25 Page:1667-1676
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Ferrari Silvia Martina¹,Patrizio Armando²,Stoppini Giulio³,Elia Giusy³,Ragusa Francesca³,Balestri Eugenia³,Botrini Chiara³,Rugani Licia³,Barozzi Emilio³,Mazzi Valeria³,La Motta Concettina⁴,Antonelli Alessandro³,Fallahi Poupak⁵

Affiliation:

1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

2. Department of Emergency Medicine, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

3. Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy

4. Department of Pharmacy, University of Pisa, Pisa, Italy

5. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2393281

Reference117 articles.

1. Diagnosis and treatment of patients with thyroid cancer;Nguyen QT;Am Health Drug Benefits,2015

2. Cancer today. [cited 2023 Sept 24]. Available from: http://gco.iarc.fr/today/home

3. Thyroid cancer mortality and incidence: A global overview

4. Thyroid cancer incidence trends by histology in 25 countries: a population-based study

5. Overview of the 2022 WHO Classification of Thyroid Neoplasms

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP